NFKB1 and neoplasm: In a significant proportion of cases, irregular activation of the NF-κB signaling pathway is believed to be related to loss-of-function mutations in tumor suppressor genes (e.g., NFKBIA, TNFAIP3) that inhibit the NF-κB signaling pathway (Weniger and Küppers, 2016).